NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma

Eudocia Q. Lee, Peixin Zhang, Patrick Y. Wen, Elizabeth R. Gerstner, David A. Reardon, Kenneth D. Aldape, John F. deGroot, Edward Pan, Jeffrey J. Raizer, Lyndon J. Kim, Steven J. Chmura, H. Ian Robins, Jennifer M. Connelly, James D. Battiste, John L. Villano, Naveed Wagle, Ryan T. Merrell, Merideth M. Wendland, Minesh P. Mehta